The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer
- PMID: 20920199
- PMCID: PMC2954853
- DOI: 10.1186/1477-7819-8-85
The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer
Abstract
Background: Acute-phase response proteins (APRP), cytokines and hormones have been claimed to be an independent prognostic factor of malignancies, however the basis for their association with prognosis remains unexplained. We suggest that in colon malignancies, as similar to pancreatic and lung cancers, changes in APRP are associated with angiogenesis.
Methods: C-reactive protein (CRP), albumin, IL-1α, IL-1β, IL-6, IL-8, IL-10, TNF-α, midkine, VEGF-A, VEGF-C, leptin, adiponectin, and ghrelin serum levels are studied in 126 colon cancer patients and 36 healthy subjects.
Results: We found statistically significant difference and correlations between two groups. We found significantly higher serum CRP, IL-1α, IL-1β, IL-6, IL-8, IL-10, TNF-α, VEGF-A, VEGF-C and leptin concentrations in patients relative to controls (p < 0.001). We found lower levels of the serum albumin, midkine, adiponectin and ghrelin in patients compared to control subjects (p < 0.001).
Conclusions: Cachexia in patients with colon cancers is associated with changes in APRP, cytokines and hormone concentrations. These biomarkers and cachexia together have a direct relationship with accelerated angiogenesis. This may lead to a connection between the outcomes in malignancies and the biomarkers.
Similar articles
-
The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic.Hum Exp Toxicol. 2012 Feb;31(2):117-25. doi: 10.1177/0960327111417271. Epub 2011 Jul 29. Hum Exp Toxicol. 2012. PMID: 21803781
-
Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers.Clin Chem Lab Med. 2008;46(3):359-64. doi: 10.1515/CCLM.2008.089. Clin Chem Lab Med. 2008. PMID: 18303990
-
Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.Int J Clin Oncol. 2009 Aug;14(4):315-20. doi: 10.1007/s10147-008-0856-1. Epub 2009 Aug 25. Int J Clin Oncol. 2009. PMID: 19705241
-
Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer.Int J Clin Pract. 2004 Jun;58(6):545-9. doi: 10.1111/j.1368-5031.2004.00149.x. Int J Clin Pract. 2004. PMID: 15311551
-
Can the acute-phase reactant proteins be used as cancer biomarkers?Int J Biol Markers. 2010 Jan-Mar;25(1):1-11. doi: 10.1177/172460081002500101. Int J Biol Markers. 2010. PMID: 20155712 Review.
Cited by
-
Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review.Endocr Relat Cancer. 2016 Sep;23(9):R393-409. doi: 10.1530/ERC-16-0130. Endocr Relat Cancer. 2016. PMID: 27552970 Free PMC article.
-
Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis.Onco Targets Ther. 2018 May 4;11:2519-2531. doi: 10.2147/OTT.S157255. eCollection 2018. Onco Targets Ther. 2018. PMID: 29765231 Free PMC article.
-
Ghrelin and its role in gastrointestinal tract tumors (Review).Mol Med Rep. 2021 Sep;24(3):663. doi: 10.3892/mmr.2021.12302. Epub 2021 Jul 23. Mol Med Rep. 2021. PMID: 34296307 Free PMC article. Review.
-
The Prognostic Value of the C-reactive Protein/Prognostic Nutritional Index Ratio in Stage III and IV Laryngeal Cancer Patients Treated with Radiotherapy.Cureus. 2019 May 12;11(5):e4648. doi: 10.7759/cureus.4648. Cureus. 2019. PMID: 31312573 Free PMC article.
-
The Optimal Timing for Initiating Anamorelin in the Treatment of Cancer Cachexia.Cureus. 2025 Apr 2;17(4):e81622. doi: 10.7759/cureus.81622. eCollection 2025 Apr. Cureus. 2025. PMID: 40330331 Free PMC article.
References
-
- Boddeart MS, Gerritsen WR, Pinedo HM. On our own way to targeted therapy for cachexia incancer. Curr Opin Oncol. 2006;18:335–340. doi: 10.1097/01.cco.0000228738.85626.ac. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous